​

Aura Biosciences Ownership | Who Owns Aura Biosciences?

OverviewForecastRevenueFinancialsChart

Aura Biosciences Ownership Summary

Aura Biosciences is owned by 88.00% institutional investors, 1.89% insiders, and 10.11% retail investors. Matrix capital management company, lp is the largest institutional shareholder, holding 11.93% of AURA shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 8.16% of its assets in Aura Biosciences shares.

AURA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAura Biosciences88.00%1.89%10.11%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Matrix capital management company, lp6.92M11.93%$42.78M
Frazier life sciences management5.10M8.79%$31.52M
Adage capital partners gp4.88M8.41%$30.17M
Long focus capital management4.62M7.96%$28.55M
Suvretta capital management4.37M7.54%$27.02M
Blackrock3.01M6.08%$22.72M
Blackrock funding, inc. /de3.41M5.87%$21.05M
Medicxi ventures management (jersey)3.04M5.24%$18.79M
Vanguard group2.89M4.98%$17.86M
Franklin resources2.20M3.79%$13.59M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Matrix capital management company, lp6.92M40.08%$42.78M
B group572.58K2.60%$3.54M
Medicxi ventures management (jersey)3.04M2.52%$18.79M
Acorn capital advisors595.74K1.87%$3.68M
Regency capital management inc.\de612.69K1.80%$3.79M
Frazier life sciences management5.10M0.94%$31.52M
Long focus capital management4.62M0.94%$28.55M
Levin capital strategies1.63M0.91%$10.06M
Suvretta capital management4.37M0.69%$27.02M
Decheng capital515.55K0.56%$3.19M

Top Buyers

HolderShares% AssetsChange
Blackrock3.01M0.00%560.52K
Vanguard group2.89M0.00%413.00K
Geode capital management1.26M0.00%327.97K
Blackrock funding, inc. /de3.41M0.00%302.95K
Permanent capital management, lp147.77K0.17%147.77K

Top Sellers

HolderShares% AssetsChange
Eventide asset management---4.08M
Samsara biocapital584.85K0.47%-415.15K
Ensign peak advisors---390.69K
Jefferies financial group---222.50K
Verition fund management---151.68K

New Positions

HolderShares% AssetsChangeValue
Permanent capital management, lp147.77K0.17%147.77K$913.21K
Walleye capital67.30K0.00%67.30K$415.89K
Prelude capital management50.00K0.02%50.00K$309.00K
Jane street group33.10K-33.10K$204.58M
Susquehanna group, llp27.34K-27.34K$224.74K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Ifp advisors-10.00
Capital performance advisors llp-25.00
Corecap advisors-33.00
True wealth design-36.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20251037.29%51,053,7131.75%871.18%53-1.85%21-25.00%
Jun 30, 20251018.60%50,603,53553.66%872.02%5732.56%29-3.33%
Mar 31, 202594-3.09%39,855,4091.03%791.26%43-27.12%3076.47%
Dec 31, 20249611.63%39,448,5527.00%791.44%5735.71%17-29.17%
Sep 30, 20248613.16%36,866,668-6.95%741.16%41-8.89%2525.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Eventide Healthcare & Life Sciences I4.08M8.16%-1.72M
Franklin Biotechnology Discv A(acc)USD1.47M2.36%-22.83K
Vanguard Total Stock Mkt Idx Inv1.37M2.20%-30.36K
iShares Russell 2000 ETF970.88K1.56%-
Franklin Biotechnology Discovery A820.94K1.32%-
Vanguard Institutional Extnd Mkt Idx Tr427.12K0.69%-194.62K
Fidelity Small Cap Index377.17K0.61%-93.22K
T. Rowe Price Health Sciences323.99K0.52%-3.64K
iShares Biotechnology ETF276.23K0.44%-
State St Russell Sm/Mid Cp® Indx SL Cl I256.14K0.41%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 17, 2025Hopkins Janet Jill Chief Medical OfficerSell$92.73K
Oct 29, 2025Elazzouzi Amy Senior Vice President, FinanceSell$5.69K
Oct 29, 2025de los Pinos Elisabet See RemarksSell$57.46K
Oct 16, 2025Plavsic Mark Chief Technology OfficerSell$77.27K
Aug 18, 2025Elazzouzi Amy Senior Vice President, FinanceSell$51.74K

Insider Transactions Trends

DateBuySell
2025 Q4-4
2025 Q3-1
2025 Q243
2025 Q1-6
2024 Q4-6

AURA Ownership FAQ

Who Owns Aura Biosciences?

Aura Biosciences shareholders are primarily institutional investors at 88.00%, followed by 1.89% insiders and 10.11% retail investors. The average institutional ownership in Aura Biosciences's industry, Biotech Stocks , is 45.24%, which Aura Biosciences exceeds.

Who owns the most shares of Aura Biosciences?

Aura Biosciences’s largest shareholders are Matrix capital management company, lp (6.92M shares, 11.93%), Frazier life sciences management (5.1M shares, 8.79%), and Adage capital partners gp (4.88M shares, 8.41%). Together, they hold 29.14% of Aura Biosciences’s total shares outstanding.

Does Blackrock own Aura Biosciences?

Yes, BlackRock owns 6.08% of Aura Biosciences, totaling 3.01M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 560.52K shares, a 22.93% change.

Who is Aura Biosciences’s biggest shareholder by percentage of total assets invested?

Matrix capital management company, lp is Aura Biosciences’s biggest shareholder by percentage of total assets invested, with 40.08% of its assets in 6.92M Aura Biosciences shares, valued at 42.78M$.

Who is the top mutual fund holder of Aura Biosciences shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Aura Biosciences shares, with 8.16% of its total shares outstanding invested in 4.08M Aura Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools